{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:12:53Z","timestamp":1759421573144,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is a spreading fibrotic disease affecting the skin and internal organs. We aimed to model pathogenic fibroblast migration in SSc in order to identify enhancing factors, measure the effect of migrating cells on underlying extracellular matrix (ECM) and test possible therapeutic inhibitors. Novel patterned collagen substrates were used to investigate alignment and migration of skin and lung fibroblasts from SSc patients and healthy controls. Normal lung but not skin fibroblasts consistently elongated and aligned with underlying collagen and migrated dependent on PDGF or serum. SSc lung fibroblasts remained growth factor dependent, did not migrate more rapidly and were less restricted to alignment of the collagen. Multiple collagen proline and lysine-modifying enzymes were identified in SSc but not control fibroblast extracellular matrix preparations, indicating differential levels of ECM modification by the diseased cells. Profiling of migrating cells revealed a possible SCF\/c-Kit paracrine mechanism contributing to migration via a subpopulation of cells. Heparin, which binds ligands including PDGF and SCF, and imatininib which blocks downstream tyrosine kinase receptors, both inhibited lung fibroblast migration individually but showed synergy in SSc cells. Pathologic lung fibroblasts from SSc patients modify ECM during migration but remain growth factor dependent and sensitive to inhibitors.<\/jats:p>","DOI":"10.1038\/s41598-017-02621-3","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T10:52:38Z","timestamp":1495709558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration"],"prefix":"10.1038","volume":"7","author":[{"given":"Bahja","family":"Ahmed Abdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Karrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Renzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athol","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oseme","family":"Etomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-7564","authenticated-orcid":false,"given":"J. Justin","family":"Hsuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Shiwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-5851","authenticated-orcid":false,"given":"David","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"2621_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli, A., Avvedimento, E. V. & Krieg, T. Scleroderma. N. Engl. J. Med. \n                           360, 1989\u20132003, doi:10.1056\/NEJMra0806188 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2621_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","volume":"10","author":"AU Wells","year":"2014","unstructured":"Wells, A. U. & Denton, C. P. Interstitial lung disease in connective tissue disease-mechanisms and management. Nat. Rev. Rheumatol. \n                           10, 728\u2013739, doi:10.1038\/nrrheum.2014.149 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2621_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/art.38390","volume":"66","author":"SI Nihtyanova","year":"2014","unstructured":"Nihtyanova, S. I. et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol. \n                           66, 1625\u20131635, doi:10.1002\/art.v66.6 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"2621_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc, R. et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J. Clin. Inves. \n                           98, 785\u2013792, doi:10.1172\/JCI118851 (1996).","journal-title":"J. Clin. Inves."},{"key":"2621_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.2322031223","volume":"232","author":"SR Desai","year":"2004","unstructured":"Desai, S. R. et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology \n                           232, 560\u2013567, doi:10.1148\/radiol.2322031223 (2004).","journal-title":"Radiology"},{"key":"2621_CR6","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles, R. K. et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum. \n                           54, 3962\u20133970, doi:10.1002\/art.22204 (2006).","journal-title":"Arthritis Rheum."},{"key":"2621_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin, D. P. et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir. Med. \n                           4, 708\u2013719, doi:10.1016\/S2213-2600(16)30152-7 (2016).","journal-title":"Lancet Respir. Med."},{"key":"2621_CR8","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/ar4606","volume":"16","author":"P Fraticelli","year":"2014","unstructured":"Fraticelli, P. et al. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res. Ther. \n                           16, R144, doi:10.1186\/ar4606 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"2621_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/art.24186","volume":"60","author":"A Akhmetshina","year":"2009","unstructured":"Akhmetshina, A. et al. Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum. \n                           60, 219\u2013224, doi:10.1002\/art.v60:1 (2009).","journal-title":"Arthritis Rheum."},{"key":"2621_CR10","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. \n                           370, 2071\u20132082, doi:10.1056\/NEJMoa1402584 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2621_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","volume":"171","author":"A Azuma","year":"2005","unstructured":"Azuma, A. et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. \n                           171, 1040\u20131047, doi:10.1164\/rccm.200404-571OC (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2621_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. \n                           19, 1047\u20131053, doi:10.1038\/nm.3218 (2013).","journal-title":"Nat. Med."},{"key":"2621_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13075-015-0575-8","volume":"17","author":"KE Clark","year":"2015","unstructured":"Clark, K. E. et al. Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis. Arthritis Res. Ther. \n                           17, 73, doi:10.1186\/s13075-015-0575-8 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"2621_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.0022-202X.2005.23629.x","volume":"124","author":"S Loffek","year":"2005","unstructured":"Loffek, S. et al. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J. Invest. Dermatol. \n                           124, 638\u2013643, doi:10.1111\/j.0022-202X.2005.23629.x (2005).","journal-title":"J. Invest. Dermatol."},{"key":"2621_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/rheumatology\/ker367","volume":"51","author":"J Frost","year":"2012","unstructured":"Frost, J. et al. Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc. Rheumatology (Oxford) \n                           51, 1049\u20131052, doi:10.1093\/rheumatology\/ker367 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"2621_CR16","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1101324","volume":"364","author":"J Kajstura","year":"2011","unstructured":"Kajstura, J. et al. Evidence for human lung stem cells. N. Engl. J. Med. \n                           364, 1795\u20131806, doi:10.1056\/NEJMoa1101324 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2621_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1067-1927.2004.012310.x","volume":"12","author":"KE Moyer","year":"2004","unstructured":"Moyer, K. E., Saggers, G. C. & Ehrlich, H. P. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen. \n                           12, 269\u2013275, doi:10.1111\/wrr.2004.12.issue-3 (2004).","journal-title":"Wound Repair Regen."},{"key":"2621_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0092-8674(90)90303-V","volume":"63","author":"E Huang","year":"1990","unstructured":"Huang, E. et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell \n                           63, 225\u2013233, doi:10.1016\/0092-8674(90)90303-V (1990).","journal-title":"Cell"},{"key":"2621_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0955-0674(91)90111-B","volume":"3","author":"P Besmer","year":"1991","unstructured":"Besmer, P. The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr. Opin. Cell Biol. \n                           3, 939\u2013946, doi:10.1016\/0955-0674(91)90111-B (1991).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2621_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1365-2133.2012.11186.x","volume":"167","author":"S Prey","year":"2012","unstructured":"Prey, S. et al. Imatinib mesylate in scleroderma\u2010associated diffuse skin fibrosis: a phase II multicentre randomized double\u2010blinded controlled trial. British Journal of Dermatology \n                           167, 1138\u20131144, doi:10.1111\/j.1365-2133.2012.11186.x (2012).","journal-title":"British Journal of Dermatology"},{"key":"2621_CR21","unstructured":"Cox, M., Nelson, D. Principles of Biochemistry (ed. Lehninger, 2004)."},{"key":"2621_CR22","doi-asserted-by":"publisher","first-page":"14961","DOI":"10.1074\/jbc.M011550200","volume":"276","author":"YJ Chuang","year":"2001","unstructured":"Chuang, Y. J. et al. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J. Biol. Chem. \n                           276, 14961\u201314971, doi:10.1074\/jbc.M011550200 (2001).","journal-title":"J. Biol. Chem."},{"key":"2621_CR23","doi-asserted-by":"crossref","unstructured":"Capila, I. & Linhardt, R. Heparin\u2013protein interactions. Angewandte Chemie International Edition \n                           41, 390\u2013412, (2002).","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B"},{"key":"2621_CR24","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1091\/mbc.E10-04-0348","volume":"21","author":"WJ Kuo","year":"2010","unstructured":"Kuo, W. J., Digman, M. A. & Lander, A. D. Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization. Mol. Biol. Cell \n                           21, 4028\u20134041, doi:10.1091\/mbc.E10-04-0348 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"2621_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1248\/bpb.31.726","volume":"31","author":"JY Cho","year":"2008","unstructured":"Cho, J. Y. Chloroquine, an anti-malarial agent, acts as a novel regulator of beta 1-integrin-mediated cell-cell adhesion. Biol. Pharm. Bull. \n                           31, 726\u2013730, doi:10.1248\/bpb.31.726 (2008).","journal-title":"Biol. Pharm. Bull."},{"key":"2621_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis, R. Transforming growth factor beta\u2013at the centre of systemic sclerosis. Nat. Rev. Rheumatol. \n                           10, 706\u2013719, doi:10.1038\/nrrheum.2014.137 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2621_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1083\/jcb.92.2.584","volume":"92","author":"H Seppa","year":"1982","unstructured":"Seppa, H., Grotendorst, G., Seppa, S., Schiffmann, E. & Martin, G. R. Platelet- derived growth factor is chemotactic for fibroblasts. J. Cell Biol. \n                           92, 584\u2013588, doi:10.1083\/jcb.92.2.584 (1982).","journal-title":"J. Cell Biol."},{"key":"2621_CR28","first-page":"373","volume":"117","author":"GF Pierce","year":"1991","unstructured":"Pierce, G. F., Brown, D. & Mustoe, T. A. Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy. J. Lab. Clin. Med. \n                           117, 373\u2013382 (1991).","journal-title":"J. Lab. Clin. Med."},{"key":"2621_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1091\/mbc.E03-05-0352","volume":"15","author":"W Li","year":"2004","unstructured":"Li, W. et al. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol. Biol. Cell. \n                           15, 294\u2013309, doi:10.1091\/mbc.E03-05-0352 (2004).","journal-title":"Mol. Biol. Cell."},{"key":"2621_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1164\/rccm.200602-205OC","volume":"174","author":"CD Cool","year":"2006","unstructured":"Cool, C. D. et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am. J. Respir. Crit. Care Med. \n                           174, 654\u2013658, doi:10.1164\/rccm.200602-205OC (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2621_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1465-9921-7-95","volume":"7","author":"M Chilosi","year":"2006","unstructured":"Chilosi, M. et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir. Res. \n                           7, 95, doi:10.1186\/1465-9921-7-95 (2006).","journal-title":"Respir. Res."},{"key":"2621_CR32","doi-asserted-by":"publisher","first-page":"e10130","DOI":"10.7554\/eLife.10130","volume":"5","author":"M Theodosiou","year":"2016","unstructured":"Theodosiou, M. et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. Elife \n                           5, e10130, doi:10.7554\/eLife.10130 (2016).","journal-title":"Elife"},{"key":"2621_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bpj.2014.05.041","volume":"107","author":"P Bun","year":"2014","unstructured":"Bun, P. et al. Mechanical checkpoint for persistent cell polarization in adhesion-naive fibroblasts. Biophys. J. \n                           107, 324\u2013335, doi:10.1016\/j.bpj.2014.05.041 (2014).","journal-title":"Biophys. J."},{"key":"2621_CR34","doi-asserted-by":"publisher","first-page":"e50742","DOI":"10.1371\/journal.pone.0050742","volume":"7","author":"RP Hill","year":"2012","unstructured":"Hill, R. P. et al. Generation and characterization of multipotent stem cells from established dermal cultures. PLoS One \n                           7, e50742, doi:10.1371\/journal.pone.0050742 (2012).","journal-title":"PLoS One"},{"key":"2621_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0923-1811(00)00164-X","volume":"26","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto, T. et al. Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis. J. Dermatol. Sci. \n                           26, 106\u2013111, doi:10.1016\/S0923-1811(00)00164-X (2001).","journal-title":"J. Dermatol. Sci."},{"key":"2621_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000017979","volume":"197","author":"T Yamamoto","year":"1998","unstructured":"Yamamoto, T., Katayama, I. & Nishioka, K. Expression of stem cell factor in the lesional skin of systemic sclerosis. Dermatology \n                           197, 109\u2013114, doi:10.1159\/000017979 (1998).","journal-title":"Dermatology"},{"key":"2621_CR37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ard.2010.143974","volume":"70","author":"RF Spiera","year":"2011","unstructured":"Spiera, R. F. et al. Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial. Ann. Rheum. Dis. \n                           70, 1003\u20131009, doi:10.1136\/ard.2010.143974 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"2621_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1074\/mcp.M900401-MCP200","volume":"9","author":"R Srirajaskanthan","year":"2010","unstructured":"Srirajaskanthan, R. et al. Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes. Mol. Cell Proteomics \n                           9, 656\u2013666, doi:10.1074\/mcp.M900401-MCP200 (2010).","journal-title":"Mol. Cell Proteomics"},{"key":"2621_CR39","doi-asserted-by":"crossref","unstructured":"Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell Proteomics \n                           11, M111 014647 (2012).","DOI":"10.1074\/mcp.M111.014647"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02621-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02621-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02621-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:48:39Z","timestamp":1671770919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-02621-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-02621-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2017,6,1]]},"assertion":[{"value":"17 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2628"}}